Wegovy is coming in pill form. Here’s when, how much, and how well it works

The FDA has approved a pill version of Wegovy, a GLP-1 weight-loss drug, offering an alternative to injections. Novo Nordisk, the manufacturer, anticipates launching the pill in the U.S. in early January, with global approvals pending. This marks an advancement in weight-loss drugs, expanding options for those uncomfortable with injections. The Wegovy pill will be available in a higher 25mg dose, unlike the existing 14mg Rybelsus. Clinical trials for the Wegovy pill began over two years ago. Eli Lilly is also developing a weight-loss pill, orforglipron, which may come to market sooner. The Wegovy pill, like the injection, will require a doctor’s prescription. Increased availability through pills could boost GLP-1 drug usage, which is already popular. Cost is a key factor, with a starting dose of Wegovy pills available for $149/month under a Trump administration plan. The pricing for the full strength dosage wasn't disclosed by Novo Nordisk.